Otsuka Pharmaceutical Company, Ltd., has become a network-wide sponsor of BioLabs in the US. The company has signed a three-year agreement with BioLabs to provide funding which will support BioLabs and their resident companies (U.S. only). As part of their sponsorship, Otsuka can award up to two Golden Tickets per year. Each Golden Ticket provides one year of fully paid individual bench space and membership at Princeton Innovation Center BioLabs (or other BioLabs U.S. sites), a fully equipped laboratory designed to accelerate early-stage startups working on research and development in novel platform technologies for discovery of novel targets, improved drug discovery, tissue tropism, delivery of large molecules, or new pharmaceutical-based therapeutic interventions. Therapeutic areas of strategic focus include, psychiatry, neurology, cardio-renal and immunology. 

More information and how to apply, can be found here.

Application deadline: Friday, July 21